BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20843124)

  • 21. Population pharmacokinetics of high-dose methotrexate in Chinese pediatric patients with medulloblastoma.
    Shi ZY; Liu YO; Gu HY; Xu XQ; Yan C; Yang XY; Yan D
    Biopharm Drug Dispos; 2020 Mar; 41(3):101-110. PubMed ID: 32017134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic investigation of low-dose methotrexate in rheumatoid arthritics Japanese patients.
    Yukawa E; Mori S; Ueda K; Nakada Y
    J Clin Pharm Ther; 2007 Dec; 32(6):573-8. PubMed ID: 18021334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population Pharmacokinetics of Intravenous Methotrexate in Patients with Hematological Malignancies: Utilization of Routine Clinical Monitoring Parameters.
    Nader A; Zahran N; Alshammaa A; Altaweel H; Kassem N; Wilby KJ
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):221-228. PubMed ID: 27059845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetic study of delayed methotrexate excretion in children with acute lymphoblastic leukemia
.
    Zang YN; Wang SZ; Qin Y; Zhang JR; Zhao LB; Wang XL
    Int J Clin Pharmacol Ther; 2019 Aug; 57(8):402-407. PubMed ID: 31232278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
    Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
    Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Population pharmacokinetics of high-dose methotrexate administered in 329 children with acute lymphoblastic leukemia].
    Zhang CY; Gu J; Li YZ; Lu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):106-10. PubMed ID: 18315911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients.
    Kawakatsu S; Nikanjam M; Lin M; Le S; Saunders I; Kuo DJ; Capparelli EV
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1339-1348. PubMed ID: 31586225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of high-dose methotrexate in pediatric patients.
    Aquerreta I; Aldaz A; Giráldez J; Sierrasesúmaga L
    Ann Pharmacother; 2002 Sep; 36(9):1344-50. PubMed ID: 12196049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding hemoglobin contribution to high-dose methotrexate disposition-population pharmacokinetics in pediatric patients with hematological malignancies.
    Škorić B; Jovanović M; Kuzmanović M; Miljković B; Vučićević K
    Eur J Clin Pharmacol; 2024 May; 80(5):697-705. PubMed ID: 38347227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients.
    Kasenda B; Rehberg M; Thürmann P; Franzem M; Veelken H; Fritsch K; Schorb E; Finke J; Lebiedz D; Illerhaus G
    Ann Hematol; 2012 Aug; 91(8):1257-64. PubMed ID: 22456893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventriculolumbar perfusion chemotherapy for the treatment of leptomeningeal carcinomatosis: a phase I study with pharmacokinetic data.
    Gwak HS; Lim HS; Shin SH; Yoo H; Han JY; Kim HT; Yun T; Lee JS; Lee SH
    Am J Clin Oncol; 2013 Oct; 36(5):491-9. PubMed ID: 22781384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.
    Lui G; Treluyer JM; Fresneau B; Piperno-Neumann S; Gaspar N; Corradini N; Gentet JC; Marec Berard P; Laurence V; Schneider P; Entz-Werle N; Pacquement H; Millot F; Taque S; Freycon C; Lervat C; Le Deley MC; Mahier Ait Oukhatar C; Brugieres L; Le Teuff G; Bouazza N;
    J Clin Pharmacol; 2018 Dec; 58(12):1541-1549. PubMed ID: 29791011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J; Hak J; Martínková J; Chládek J
    Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose methotrexate for intraocular lymphoma.
    Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
    Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats.
    Dukic S; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Gourdier B; Vistelle R
    Pharm Res; 1999 Aug; 16(8):1219-25. PubMed ID: 10468023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing population pharmacokinetic parameters for high-dose methotrexate therapy: implication of correlations among developed parameters for individual parameter estimation using the Bayesian least-squares method.
    Watanabe M; Fukuoka N; Takeuchi T; Yamaguchi K; Motoki T; Tanaka H; Kosaka S; Houchi H
    Biol Pharm Bull; 2014; 37(6):916-21. PubMed ID: 24882404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer.
    Bressolle F; Joulia JM; Pinguet F; Ychou M; Astre C; Duffour J; Gomeni R
    Cancer Chemother Pharmacol; 1999; 44(4):295-302. PubMed ID: 10447576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients.
    Latz JE; Chaudhary A; Ghosh A; Johnson RD
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):401-11. PubMed ID: 16322991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 2- and 3-compartment models for the Bayesian estimation of methotrexate pharmacokinetics.
    Sabot C; Debord J; Roullet B; Marquet P; Merle L; Lachatre G
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):164-9. PubMed ID: 7599915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.
    Simon N; Marsot A; Villard E; Choquet S; Khe HX; Zahr N; Lechat P; Leblond V; Hulot JS
    Pharmacogenomics J; 2013 Dec; 13(6):507-13. PubMed ID: 23069858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.